In Korean adults, eating nuts is linked to the greatest reduction in death risk among those with a body mass index (BMI) of 23–25 — a range considered overweight by Korean standards — but not among those who are underweight or obese.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A meta-analysis could determine whether the BMI-specific benefit of nuts (strongest at 23–25 kg/m²) is consistent across populations using different BMI cutoffs.
A systematic review and meta-analysis of all prospective cohort studies reporting hazard ratios for all-cause mortality by nut intake, stratified by BMI categories using local cutoffs (e.g., <23, 23–25, ≥25 for Asians), with standardized adjustment for waist circumference and metabolic health.
An RCT could test whether adding nuts to the diet of individuals with BMI 23–25 reduces mortality more than in those with BMI <23 or ≥25.
A double-blind RCT of 6,000 Korean adults aged 50–75, stratified by BMI into three groups (18.5–22.9, 23–25, 25.1–30), randomized to consume 30g of nuts daily or placebo for 12 years, with all-cause mortality as primary endpoint.
Another cohort could replicate whether the BMI-nut interaction holds in a different Asian population with similar weight distributions.
A prospective cohort of 75,000 adults aged 40–80 in Japan or Taiwan, measuring BMI at baseline and every 5 years, nut intake via FFQ, and tracking mortality over 20 years, adjusting for waist-to-hip ratio and metabolic syndrome.
A case-control study could compare past nut intake among individuals with BMI 23–25 who died versus those who survived, testing whether the association is stronger in this group.
A matched case-control study of 1,200 deceased adults with BMI 23–25 and 1,200 survivors, matched for age, sex, and physical activity, with detailed dietary recall of nut intake over the prior 10 years.
A cross-sectional study could examine whether individuals with BMI 23–25 who eat nuts have better metabolic markers than those with other BMI ranges.
A national survey of 12,000 Korean adults aged 45–75 measuring BMI, nut intake via FFQ, and metabolic biomarkers (insulin, HbA1c, triglycerides, CRP) in a single visit, stratified by BMI category.